111
Views
27
CrossRef citations to date
0
Altmetric
Original Research

Astrogliosis in ALS: possible interpretations according to pathogenetic hypotheses

&
Pages 22-25 | Received 22 Jan 2003, Accepted 21 Aug 2003, Published online: 10 Jul 2009

References

  • Hampton RY. ER stress response: getting UPR hand on misfolded proteins. Curr Biol 2000; 10: 18–21.
  • Rosen DR, Siddique T, Patterson D et al. Mutations in Cu/Zn superoxide dismutase gene are associated with amyotrophic lateral sclerosis. Nature 1993; 362: 59–62.
  • Rothstein JD, Martin L, Levey AI et al. Localisation of neuronal and glial glutamate transporters. Neuron 1994; 13: 713–725.
  • Rothstein JD, Van Kammen M, Levey AI, Martin LJ, Kuncl RW. Selective loss of glial glutamate transporter GLT-1 in amyo- trophic lateral sclerosis. Ann Neurol 1995; 38: 73–84.
  • Rothstein JD, Dykes-Hoberg M, Pardo CA. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 1996; 16: 674–686.
  • Schiffer D, Cordera S, Cavalla P, Migheli A. Reactive astrogliosis of the spinal cord in amyotrophic lateral sclerosis. J Neurol Sci 1996; 139 (suppl): 27–35.
  • Iwatsubo T, Kuzuhara S, Kanemitsu A, Shimada H, Toyokura Y. Corticofugal projections to the motor nuclei of the brainstem and spinal cord in humans. Neurology 1990; 40: 309–312.
  • Schiffer D, Attanasio A, Chio` A, Migheli A, Pezzullo T. Ubiquitinated dystrophic neurites suggest corticospinal degen- eration in patients with amyotrophic lateral sclerosis. Neurosci Lett 1994; 180: 21–24.
  • Sitte HH, Wanschitz J, Budka H, Berger ML. Autoradiography with [3H]PK11195 of spinal tract degeneration in amyotrophic lateral sclerosis. Acta Neuropathol 2001; 101: 75–78.
  • Aronica E, Catania MV, Geurts J, Yankayaa B, Troost D. Immunohistochemical localisation of group I and II metabo- tropic glutamate receptors in control and amyotrophic lateral sclerosis human spinal cord: upregulation in reactive astrocytes. Neurosci 2001; 105: 509–520.
  • Cassina P, Peluffo H, Pehar M et al. Peroxynitrite triggers a phenotypic transformation in spinal cord astrocytes that induces motor neuron apoptosis. J Neurosci Res 2002; 67: 21–29.
  • Anneser JMH, Cookson MR, Ince PG, Shaw PJ, Borasio GD. Glial cells of the spinal cord and subcortical white matter upregulate neuronal nitric oxide synthase in sporadic amyotrophic lateral sclerosis. Exp Neurol 2001; 171: 418–421.
  • Kamo H, Haebara H, Akiguchi I, Kameyama M, Rimura H, McGeer PL. A distinctive distribution of reactive astroglia in the precentral cortex in amyotrophic lateral sclerosis. Acta Neuropathol 1987; 74: 33–38.
  • Troost D, Sillevis Smitt PAE, De Jong JMBV, Swaab DS. Neurofilament and glial alterations in the cerebral cortex in amyotrophic lateral sclerosis. Acta Neuropathol 1992; 84: 664–673.
  • Murayama S, Inoue K, Kawakami H, Bouldin TW, Suzuki K. A unique pattern of astrocytosis in the primary motor area in amyotrophic lateral sclerosis. Acta Neuropathol 1991; 82: 456–461.
  • Nagy D, Kato T, Kushner PD. Reactive astrocytes are widespread in the cortical grey matter of amyotrophic lateral sclerosis. J Neurosci Res 1994; 38: 336–347.
  • Kushner PD, Stephenson DT, Wright S. Reactive astrogliosis is widespread in subcortical white matter of amyotrophic lateral sclerosis brain. J Neuropathol Exp Neurol 1991; 50: 263–277.
  • Feigin I. Astrocytic changes in white matter of ALS brains (letter to the editor). J Neuropathol Exp Neurol 1991; 50: 678–679.
  • Hayashi H, Kato S. Total manifestations of amyotrophic lateral sclerosis. J Neurol Sci 1989; 93: 19–35.
  • Mizutani T, Sakamaki S, Tsuchiya N et al. Amyotrophic lateral sclerosis with ophthalmoplegia and multisystem degeneration in patients on long-term use of respirators. Acta Neuropathol 1992; 84: 372–377.
  • Wong PC, Pardo CA, Borchelt DR et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 1995; 4: 11051–1116.
  • Bruijn LI, Becher MW, Lee MK et al. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 1997; 18: 327–338.
  • Feeney SJ, McKelvie PA, Austin L et al. Presymptomatic motor neuron loss and reactive astrocytosis in the SOD1 mouse model of amyotrophic lateral sclerosis. Muscle Nerve 2001; 4: 1510–1519.
  • Hall ED, Oostveen JO, Gurney ME. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia 1998; 23: 249–256.
  • Cha IC, Kim J-N, Shin DH et al. Reactive astrocytes express nitric oxide synthase in the spinal cord of transgenic mice expressing a human Cu/Zn SOD mutation. NeuroReport 1998; 9: 1503–1506.
  • Almer G, Vukosavic S, Romero N et al. Inducible nitric oxide synthase upregulation in a transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 1999; 72: 2415–2425.
  • Levine JB, Kong J, Nadler M, Xu Z. Astrocytes interact intimately with degenerating motor neurons in mouse amyotrophic lateral sclerosis (ALS). Glia 1999; 28: 215–224.
  • Trotti D, Rolfs A, Danbolt NC, Brown Jr RH, Hediger MA. SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter. Nat Neurosci 1999; 2: 427–433.
  • Gong YU, Parsadanian AS, Andreeva A, Snider WD, Elliot JL. Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motor neuron degeneration. J Neurosci 2000; 15: 660–665.
  • Ferri A, Casciati A, Cozzolino M, Nencini M, Rotilio G, Carr`ı MT. Cross-talk between neuroblastoma and glioblastoma FALS models. Amyotr Lat Scl 2002; 3, (suppl 2): 25–26.
  • Shibata N, Hirano A, Hedely-White TE et al. Selective formation of certain advanced glycation end products in spinal cord astrocytes of humans and mice with superoxide dismutase-1 mutation. Acta Neuropathol 2002; 104: 171–178.
  • Pedersen WA, Cahman NR, Mattson MP. The lipid peroxida- tion product 4-hydroxynonenal in the spinal cords of amyo- trophic lateral sclerosis patients. Ann Neurol 1999; 44: 819–824.
  • Shibata N, Nagai R, Uchida K et al. Morphological evidence of lipid peroxidation and protein glycoxidation in spinal cords from sporadic amyotrophic lateral sclerosis patients. Brain Res 2001; 917: 97–104.
  • Cleveland DW. From Charcot to SOD1: mechanisms of selective motor neuron death in ALS. Neuron 1999; 9: 515–520.
  • Dal Canto MC, Gurney ME. Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu/Zn SOD and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis. Brain Res 1995; 676: 25–40.
  • Olsen MK, Steven BA, Roberds L et al. Disease mechanisms revealed by transcription profiling in SOD1-G93A transgenic mouse spinal cord. Ann Neurol 2001; 50: 730–740.
  • Klivenyi P, Ferranter RJ, Matthews RT et al. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nature Med 1999; 5: 347–350.
  • Tacconi MT. Neuronal death: is there a role for astrocytes? Neurochem Res 1998; 23: 759–765.
  • Bezzi P, Volterra A. A neuron-glia signalling network in the active brain. Curr Opinion Neurobiol 2001; 11: 387–394.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.